Fabulous news - especially - The FDA has also informed the company that at this time they are not planning to hold an Advisory Committee meeting.
- Forums
- ASX - By Stock
- NEU
- Ann: Rett Syndrome NDA accepted for Priority Review by FDA
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.32%
!
$14.55

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.55 |
Change
0.190(1.32%) |
Mkt cap ! $1.797B |
Open | High | Low | Value | Volume |
$14.49 | $14.61 | $14.32 | $2.489M | 172.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 482 | $14.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.56 | 343 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 256 | 14.510 |
4 | 580 | 14.500 |
4 | 1104 | 14.490 |
6 | 1188 | 14.480 |
9 | 1491 | 14.470 |
Price($) | Vol. | No. |
---|---|---|
14.530 | 921 | 15 |
14.540 | 749 | 7 |
14.550 | 3295 | 12 |
14.560 | 1588 | 8 |
14.570 | 1290 | 5 |
Last trade - 15.42pm 15/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online